Acceleron

Biotechnology ResearchUnited States51-200 Employees

Acceleron is a biotechnology research company focused on the discovery, development, and commercialization of therapeutics targeting the transforming growth factor-beta (TGF-β) superfamily to address serious and rare diseases. Based in the United States, the firm operates within the biotechnology sector and emphasizes scientific research to bring novel therapies to market. Its activities are centered on advancing drug candidates through development and potential commercialization, positioning it within a competitive landscape of biopharma players pursuing targeted biologics and specialty medicines.

The company serves customers in the biomedical and healthcare fields, including patients with rare conditions, and collaborates through its research and development programs to address unmet medical needs. While detailed product specifics are not provided in the available information, Acceleron is described as dedicated to the discovery and development of therapeutics, reflecting its focus on translating scientific insight into potential treatments for complex diseases.

Sign up for free to view info

Email Format Employee directory